News 2024年 05月 24日 Geistlich receives EU certification for collagen portfolio Geistlich Pharma has received MDR certification for its collagen product range and thus meets the new EU requirements. The products will be used ...
News 2024年 05月 22日 CUTISS secures 25 million Swiss francs from investors CUTISS has closed a first Series C financing round in the amount of 25 million Swiss francs. With this, the life sciences company with a focus on...
News 2024年 05月 24日 Health Innovation Hub drives medical innovation Switzerland Innovation Park East has opened its Health Innovation Hub in St.Gallen. The hub serves as a platform for initiating, promoting and ac...
News 2024年 05月 21日 InSphero partners with Genome Biologics The biotech company InSphero has signed an agreement with Genome Biologics to commercialize the 3D Cardiac Organoid Platform. The platform is at ...
News 2024年 05月 15日 Allegria Therapeutics raises 3.5 million dollars in seed financing round Allegria Therapeutics has received seed funding of 3.5 million dollars from the founding investor Forty51 Ventures. The biotech startup is develo...
News 2024年 05月 10日 BioVersys extends Series C financing round to 44.9 million Swiss francs BioVersys is bolstering its partnership with GSK in order to accelerate the development of alpibectir for the treatment of tuberculosis. GSK is s...
News 2024年 05月 08日 B. Braun Medical opens new factory in Sempach B. Braun Medical AG has commenced operations at a new production facility for disinfectant and hygiene products in Sempach. The company has inves...
Actualités 2024年 04月 30日 Les Grands Titres de Suisse occidentale (Avril 2024) De percées biotechnologiques à la transformation des essais cliniques, en passant par des avancées dans le domaine des matériaux écologiques et d...
News 2024年 05月 07日 UZH researching innovative cancer therapy Researchers from the University of Zurich (UZH) are in the process of developing new cancer therapeutics. Known as radiotheranostics, these drugs...
News 2024年 05月 03日 Basel research paves way for new drugs Chemists at the University of Basel have developed a new synthesis approach to artificially create terpenes. These contain substances that can be...
News 2024年 04月 30日 Top Stories from Western Switzerland (April 2024) From biotech breakthroughs and the transformation of clinical trials to advancements in eco-friendly materials and renewable energy initiatives, ...
News 2024年 04月 30日 Johnson & Johnson opens Innovation Hub in Allschwil Johnson & Johnson has opened its first J&J Innovation Hub on the European mainland at the Switzerland Innovation Park Basel Area. This represents...
Actualités 2024年 04月 23日 Les orthèses de poignet innovantes imprimées en 3D de Swibrace passent à la phase clinique Swibrace, en partenariat avec l’Inselspital de Berne, fait passer ses attelles de poignet personnalisées en phase clinique, améliorant ainsi le t...
Actualités 2024年 04月 17日 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...
News 2024年 04月 25日 Swiss biotech achieves record revenues in 2023 Swiss biotech companies generated record revenues of 7.3 billion Swiss francs in 2023, while capital investments rose 50 per cent year on year to...
Actualités 2024年 04月 09日 Sitem Startup Club et CSEM forgent un partenariat stratégique pour stimuler l’innovation medtech Ensemble, Sitem Startup Club et le CSEM exploreront le potentiel de leurs forces combinées pour faire des progrès significatifs dans l’innovation...
News 2024年 04月 23日 Swibrace advances to clinical phase with innovative 3D-printed wrist braces Swibrace, in partnership with the Inselspital in Bern, moves its customized wrist braces into clinical phase, enhancing fracture treatment throug...
News 2024年 04月 15日 First BOOM Summit deemed a success The organizers of the BOOM Summit are describing the first edition as a success. In total, 500 experts exchanged their knowledge and expertise at...